vs

Side-by-side financial comparison of Apyx Medical Corp (APYX) and BOSTON OMAHA Corp (BOC). Click either name above to swap in a different company.

BOSTON OMAHA Corp is the larger business by last-quarter revenue ($29.7M vs $19.2M, roughly 1.6× Apyx Medical Corp). Apyx Medical Corp runs the higher net margin — -6.8% vs -23.1%, a 16.3% gap on every dollar of revenue. On growth, Apyx Medical Corp posted the faster year-over-year revenue change (34.7% vs 6.4%). Apyx Medical Corp produced more free cash flow last quarter ($-2.8M vs $-10.0M). Over the past eight quarters, Apyx Medical Corp's revenue compounded faster (36.8% CAGR vs 7.8%).

Bovie Medical Corporation was an American medical device manufacturer of medical devices, electrosurgical products and energy technologies. It was based in Clearwater, Florida with a manufacturing facility in Bulgaria.

Boston Omaha Corporation is a publicly traded diversified holding company. Its core operating segments include outdoor advertising, surety insurance, residential real estate development, and fixed wireless broadband services, primarily serving customers across the United States, with a focus on driving long-term shareholder value via strategic acquisitions and organic operational growth.

APYX vs BOC — Head-to-Head

Bigger by revenue
BOC
BOC
1.6× larger
BOC
$29.7M
$19.2M
APYX
Growing faster (revenue YoY)
APYX
APYX
+28.4% gap
APYX
34.7%
6.4%
BOC
Higher net margin
APYX
APYX
16.3% more per $
APYX
-6.8%
-23.1%
BOC
More free cash flow
APYX
APYX
$7.2M more FCF
APYX
$-2.8M
$-10.0M
BOC
Faster 2-yr revenue CAGR
APYX
APYX
Annualised
APYX
36.8%
7.8%
BOC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
APYX
APYX
BOC
BOC
Revenue
$19.2M
$29.7M
Net Profit
$-1.3M
$-6.9M
Gross Margin
62.6%
64.0%
Operating Margin
0.1%
-4.2%
Net Margin
-6.8%
-23.1%
Revenue YoY
34.7%
6.4%
Net Profit YoY
71.9%
-228.1%
EPS (diluted)
$-0.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
APYX
APYX
BOC
BOC
Q4 25
$19.2M
$29.7M
Q3 25
$12.9M
$28.7M
Q2 25
$11.4M
$28.2M
Q1 25
$9.4M
$27.7M
Q4 24
$14.2M
$27.9M
Q3 24
$11.5M
$27.7M
Q2 24
$12.1M
$27.1M
Q1 24
$10.2M
$25.6M
Net Profit
APYX
APYX
BOC
BOC
Q4 25
$-1.3M
$-6.9M
Q3 25
$-2.0M
$-2.6M
Q2 25
$-3.8M
$-2.3M
Q1 25
$-4.2M
$-669.3K
Q4 24
$-4.6M
$5.3M
Q3 24
$-4.7M
$-1.6M
Q2 24
$-6.6M
$-2.2M
Q1 24
$-7.6M
$-2.8M
Gross Margin
APYX
APYX
BOC
BOC
Q4 25
62.6%
64.0%
Q3 25
64.4%
66.2%
Q2 25
62.3%
66.1%
Q1 25
60.1%
67.3%
Q4 24
63.0%
69.5%
Q3 24
60.5%
67.5%
Q2 24
61.7%
68.2%
Q1 24
58.1%
67.9%
Operating Margin
APYX
APYX
BOC
BOC
Q4 25
0.1%
-4.2%
Q3 25
-6.5%
-3.7%
Q2 25
-22.6%
-2.9%
Q1 25
-32.4%
-2.9%
Q4 24
-21.4%
-4.6%
Q3 24
-31.6%
-2.7%
Q2 24
-45.7%
-16.2%
Q1 24
-64.6%
-8.1%
Net Margin
APYX
APYX
BOC
BOC
Q4 25
-6.8%
-23.1%
Q3 25
-15.4%
-9.0%
Q2 25
-33.2%
-8.2%
Q1 25
-44.0%
-2.4%
Q4 24
-32.5%
19.1%
Q3 24
-40.9%
-5.8%
Q2 24
-54.0%
-8.3%
Q1 24
-74.0%
-11.0%
EPS (diluted)
APYX
APYX
BOC
BOC
Q4 25
$-0.23
Q3 25
$-0.08
Q2 25
$-0.07
Q1 25
$-0.02
Q4 24
$0.17
Q3 24
$-0.05
Q2 24
$-0.19
$-0.07
Q1 24
$-0.22
$-0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
APYX
APYX
BOC
BOC
Cash + ST InvestmentsLiquidity on hand
$31.7M
$56.8M
Total DebtLower is stronger
$37.5M
$25.7M
Stockholders' EquityBook value
$14.5M
$516.1M
Total Assets
$66.8M
$713.1M
Debt / EquityLower = less leverage
2.58×
0.05×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
APYX
APYX
BOC
BOC
Q4 25
$31.7M
$56.8M
Q3 25
$25.1M
$67.6M
Q2 25
$29.3M
$68.6M
Q1 25
$31.0M
$69.2M
Q4 24
$31.7M
$73.2M
Q3 24
$28.0M
$58.6M
Q2 24
$32.7M
$53.1M
Q1 24
$37.3M
$53.4M
Total Debt
APYX
APYX
BOC
BOC
Q4 25
$37.5M
$25.7M
Q3 25
$37.5M
$25.9M
Q2 25
$37.5M
$26.1M
Q1 25
$37.5M
$26.3M
Q4 24
$37.5M
$26.5M
Q3 24
$37.5M
$26.7M
Q2 24
$26.9M
Q1 24
$27.1M
Stockholders' Equity
APYX
APYX
BOC
BOC
Q4 25
$14.5M
$516.1M
Q3 25
$5.8M
$528.4M
Q2 25
$7.3M
$531.0M
Q1 25
$10.5M
$533.3M
Q4 24
$14.2M
$532.8M
Q3 24
$11.0M
$527.7M
Q2 24
$14.7M
$530.5M
Q1 24
$20.3M
$536.2M
Total Assets
APYX
APYX
BOC
BOC
Q4 25
$66.8M
$713.1M
Q3 25
$57.4M
$721.4M
Q2 25
$58.2M
$730.6M
Q1 25
$60.2M
$730.8M
Q4 24
$64.8M
$728.3M
Q3 24
$60.7M
$711.9M
Q2 24
$65.4M
$723.1M
Q1 24
$70.7M
$757.3M
Debt / Equity
APYX
APYX
BOC
BOC
Q4 25
2.58×
0.05×
Q3 25
6.41×
0.05×
Q2 25
5.17×
0.05×
Q1 25
3.57×
0.05×
Q4 24
2.64×
0.05×
Q3 24
3.40×
0.05×
Q2 24
0.05×
Q1 24
0.05×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
APYX
APYX
BOC
BOC
Operating Cash FlowLast quarter
$-2.5M
$17.9M
Free Cash FlowOCF − Capex
$-2.8M
$-10.0M
FCF MarginFCF / Revenue
-14.6%
-33.8%
Capex IntensityCapex / Revenue
1.4%
93.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-9.1M
$-17.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
APYX
APYX
BOC
BOC
Q4 25
$-2.5M
$17.9M
Q3 25
$-3.5M
$4.9M
Q2 25
$-1.2M
$4.6M
Q1 25
$-702.0K
$2.6M
Q4 24
$-2.9M
$21.2M
Q3 24
$-4.4M
$5.2M
Q2 24
$-4.3M
$4.5M
Q1 24
$-6.3M
$2.4M
Free Cash Flow
APYX
APYX
BOC
BOC
Q4 25
$-2.8M
$-10.0M
Q3 25
$-4.1M
$-489.4K
Q2 25
$-1.5M
$-2.7M
Q1 25
$-757.0K
$-4.3M
Q4 24
$-3.2M
$-11.0M
Q3 24
$-4.6M
$-1.2M
Q2 24
$-4.6M
$-4.3M
Q1 24
$-6.4M
$-6.0M
FCF Margin
APYX
APYX
BOC
BOC
Q4 25
-14.6%
-33.8%
Q3 25
-31.5%
-1.7%
Q2 25
-13.2%
-9.7%
Q1 25
-8.0%
-15.5%
Q4 24
-22.4%
-39.2%
Q3 24
-40.0%
-4.4%
Q2 24
-38.0%
-15.9%
Q1 24
-62.2%
-23.6%
Capex Intensity
APYX
APYX
BOC
BOC
Q4 25
1.4%
93.9%
Q3 25
4.0%
18.9%
Q2 25
2.3%
25.9%
Q1 25
0.6%
24.7%
Q4 24
1.7%
115.3%
Q3 24
1.3%
23.2%
Q2 24
2.4%
32.6%
Q1 24
0.3%
33.1%
Cash Conversion
APYX
APYX
BOC
BOC
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
3.97×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

APYX
APYX

Segment breakdown not available.

BOC
BOC

Billboard Rentals$11.9M40%
Equity Method Investment Nonconsolidated Investee Or Group Of Investees$10.0M34%
GIG$7.3M25%
Other$608.4K2%

Related Comparisons